RealEndpoints retweeted
From @RealEndpoints: A Solution to the #Medicare Copay Problem
Read the article: drugch.nl/34B2lws
Register for the free webcast: drugch.nl/34icJce
#ad
LAST CHANCE TO REGISTER
Join Real Endpoints on Wednesday, June 23rd as we share real-world insights into the preparation, negotiation, execution and reconciliation of innovative contracts to drive market access.
Register here: bit.ly/3oTDWs5
Real Endpoints Marketplace for addressing high cost orphan medical benefit drugs is included in MIT’s white paper on emerging market solutions to address coverage and reimbursement challenges faced by durable #cellandgenetherapies.
Read Here: bit.ly/3iO28er
With the #FDA’s landmark decision to approve #Aduhelm, payers are faced with an incredibly difficult decision – that is, how to provide affordable access to appropriate patients.
How do you think payers will respond?
bit.ly/3x1llgg
Real Endpoints CEO, Jeff Berkowitz, recently sat down with Life Science Leader to discuss his experiences and lessons learned from transitioning to an adjacent industry.
Read Jeff's advice for others who are considering the same. #careeradvice
bit.ly/3f1yyzJ
ICER and experts at Memorial Sloan Kettering’s drug pricing lab review the process, challenges and potential reforms to the FDA's accelerated approval process.
Read here: bit.ly/3uaFAHG
Do you know what employers are hearing, what they are looking for from payers, and how that will impact access for your brand? Hint: no free passes… #marketaccess #specialtypharmacy #biologics #pharma
Read Here: bit.ly/3e2sQMg
Manufacturers think CMS bars them from helping #Medicare patients afford their medicines. This is incorrect.
Join the RE webinar to understand how patient services can help ensure affordable access for Medicare Beneficiaries. #marketaccess
Register: bit.ly/39QcqVW
CVSHealth recently released their Health Trends Report 2021 highlighting the opportunities that continue to arise from the challenges of 2020. It’s no surprise that technology, from EHR’s to virtual care, continues to hold the spotlight. #marketaccess
bit.ly/3rZovOF
So — do ICER evaluations really impact how companies price their products? Well, yeah.
#Marketaccess #pharma #healthcare #ICER #drugpricing
Read Here: bit.ly/2PSJKVi
Last week #Amazon announced plans to expand #AmazonCare virtual health services nationally. This is another intentional step towards a disruptive model focused on becoming an integral part of the healthcare ecosystem and forcing change. #Pharma #telehealth
bit.ly/31yvjs4
#CellTherapy and #GeneTherapy continue to grow with 2021 likely to be a record year for the number of regulatory decisions on new regenerative medicine products. Payers continue to watch the evolution of this space closely to address challenges.
Read Here bit.ly/3cYeVWV
Worth reading the WSJ article on net-price declines for what it says, more for what it doesn’t. Net prices are decreasing in competitive spaces, but not in cancer/rare disease — which is where pharma is going. #pharma #healthcare #RareDisease #oncology
bit.ly/2Ozpurl
Equity and inclusion are fundamental to enable each of us to bring our best to our teams and organizations every day. Real Endpoints celebrates #internationalwomensday2021 as we salute our female colleagues.
#ChooseToChallenge #WeCanDoIt #IWD2021 #IWD @womensday
Check out the @PharmaScrip 2021 Pharma Trends Report where Real Endpoints’ Founder and Chairman, @RealEndptsRog joins top industry thought leaders to provide predictions for the major trends facing the industry in 2021. #healthcare #marketaccess
See here: bit.ly/2NU8LyQ
As we approach #RareDiseaseDay the #RealEndpoints team thinks about tackling the tough issues around coverage and reimbursement and assuring #PatientAccess @rarediseaseday #raredisease #pharmaceuticals #marketaccess
Can #pharma be doing more to reach patients from underrepresented groups and remove barriers? Partnering with @SHG_PerfectData and @RomAnalytics RE conducted a study to see if there were blind spots for PSS pertaining to diversity and inclusion.
Read here: bit.ly/3pZ7OSR
Can the pharma industry capitalize on its recent rehab and benefit patients by using value based contracting? The RE Marketplace for VBCs is the perfect platform for partnering with payers.
Read here: bit.ly/2ZEu21t
Learn about RE Marketplace: bit.ly/3burvwr
Our CEO, @Berkowij joined @jimbojoyce and @HealthEugene for their podcast #TheShot of #DigitalHealth. Listen for a discussion on the early days of pharma market access, digital therapeutics, & #RealEndpoints revolutionary approach to VBAs.
Watch here: bit.ly/373RtWm
Options, Expertise and Risk Tolerance say it all! The Real Endpoints Marketplace for #ValueBasedContracting addresses all of these. Contact us for expert support in developing and placing these arrangements.
Read on our LinkedIn: bit.ly/2KUN1B8








